FMT

FMT

2939 bookmarks
Custom sorting
We thought how to ⬇️ PA? #MachineLearning A. putredinis 🦠as a leading #microbial taxon predictive of low PA. We performed an #FMT with fecal microbiota containing A. putredinis and saw significant suppression of PA in our high PA #IBS #humanized
We thought how to ⬇️ PA? #MachineLearning A. putredinis 🦠as a leading #microbial taxon predictive of low PA. We performed an #FMT with fecal microbiota containing A. putredinis and saw significant suppression of PA in our high PA #IBS #humanized
We thought how to ⬇️ PA? #MachineLearning A. putredinis 🦠as a leading #microbial taxon predictive of low PA. We performed an #FMT with fecal microbiota containing A. putredinis and saw significant suppression of PA in our high PA #IBS #humanized 🐭6/11— Adam Edwinson (@AdamEdwinson) April 29, 2022
·twitter.com·
We thought how to ⬇️ PA? #MachineLearning A. putredinis 🦠as a leading #microbial taxon predictive of low PA. We performed an #FMT with fecal microbiota containing A. putredinis and saw significant suppression of PA in our high PA #IBS #humanized
Metabolic Role and Therapeutic Potential of the Microbiome
Metabolic Role and Therapeutic Potential of the Microbiome
Abstract. We are host to an assembly of microorganisms that vary in structure and function along the length of the gut and from the lumen to the mucosa. This ec
·academic.oup.com·
Metabolic Role and Therapeutic Potential of the Microbiome
Pitt Hopkins Research Foundation on Twitter
Pitt Hopkins Research Foundation on Twitter
Are you planning to be at the Pitt Hopkins Conference in June? Join us to get an update from Drs. James Adams and Rosa Krajmalnik-Brown on the Pitt Hopkins Microbiota Transfer Therapy study that was recently completed! Details: https://t.co/g1ndPUO1ux#pitthopkins #FMT #research pic.twitter.com/bamQcoUsnK— Pitt Hopkins Research Foundation (@PittHopkins) April 20, 2022
·twitter.com·
Pitt Hopkins Research Foundation on Twitter
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis | Scientific Reports
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis | Scientific Reports
Scientific Reports - Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis
·nature.com·
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis | Scientific Reports
Find a little help from my (microbial) friends - PubMed
Find a little help from my (microbial) friends - PubMed
Modulation of the microbiota to improve clinical outcomes remains challenging partially because of the large variability in biotherapeutic composition. In this issue of Cell Host & Microbe, Dsouza and colleagues present the phase 1 study results of a defined microbial consortia developed for the …
·pubmed.ncbi.nlm.nih.gov·
Find a little help from my (microbial) friends - PubMed
Tend’s Gut Microbiome Collection and Prep (CAP) Device
Tend’s Gut Microbiome Collection and Prep (CAP) Device
Thomas Lendvay discusses Clinical Study for Tend’s Gut Microbiome Collection and Prep (CAP) Device in Clostridium difficile ​Infection
·healthprofessionalradio.com.au·
Tend’s Gut Microbiome Collection and Prep (CAP) Device
Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient
Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient
We report a case of a 15-year-old girl who developed refractory Clostridioides difficile infection (CDI) after allogeneic bone marrow transplantation (BMT). She was treated successfully with fecal microbiota transplantation (FMT). The patient who had aplastic anemia underwent allogeneic BMT from an …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis
Scientific Reports - Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis
·analytics.twitter.com·
Strain-resolved analysis in a randomized trial of antibiotic pretreatment and maintenance dose delivery mode with fecal microbiota transplant for ulcerative colitis
OpenBiome on Twitter
OpenBiome on Twitter
“Can bacteria be used to address some of the most difficult-to-treat illnesses? Excited to share our work with #FMT and #Cdiff, and also discuss what’s next for #microbiome research. Thank you to @cambridgepl for hosting!”
·twitter.com·
OpenBiome on Twitter
Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application - PubMed
Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application - PubMed
Fecal microbiota transplantation (FMT) has been established as a highly restorative therapeutic approach for treating recurrent Clostridioides difficile infection (rCDI). Recently, the use of capsule-based fecal microbiota transplantation (cFMT) has been shown to be a clinically effective app …
·pubmed.ncbi.nlm.nih.gov·
Encapsulated Fecal Microbiota Transplantation: Development, Efficacy, and Clinical Application - PubMed
Australasian Human Microbiome Research Network on Twitter
Australasian Human Microbiome Research Network on Twitter
New review out by @hannahrwardill and @Dr_IlaPagani from @sahmriAU and @UniofAdelaide discussing the role of the #microbiota in leukaemia relapse and progression. #cancer #bloodcancer #gut #bacteria #probiotics #FMT https://t.co/ZZKEVJmwKd— Australasian Human Microbiome Research Network (@microbiome_net) April 3, 2022
·twitter.com·
Australasian Human Microbiome Research Network on Twitter
Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
Fecal microbiota transplantation (FMT) has the potential to restore (bacterial and fungal) microbial imbalance in ulcerative colitis (UC) patients and contribute to disease remission. Here, we aimed to identify fecal fungal species associated with the induction of clinical remission and endoscopic response to FMT for patients with mild-to-moderate ulcerative colitis. We analyzed the internal transcribed spacer 1 (ITS1)-based mycobiota composition in fecal samples from patients (n = 31) and donors (n = 7) that participated previously in a double-blinded randomized control trial evaluating the efficacy of two infusions of donor FMT compared with autologous FMT. The abundance of the yeast genus Filobasidium in fecal material used for transplantation was shown to correlate with clinical remission following FMT, irrespective of its presence in the material of donor or autologous fecal microbiota transfer. The amplified sequence variants within the genus Filobasidium most closely resembled Filobasidium magnum. Monocyte-derived macrophages and HT29 epithelial cells were stimulated with fungal species. Especially Filobasidium floriforme elicited an IL10 response in monocyte-derived macrophages, along with secretion of other cytokines following stimulation with other Filobasidium species. No effect of Filobasidium spp. was seen on epithelial wound healing in scratch assays. In conclusion, the enriched presence of Filobasidium spp. in donor feces is associated with the positive response to FMT for patients with UC and hence it may serve as a predictive fungal biomarker for successful FMT.
·t.co·
Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
Tend Announces Initiation of Clinical Study Evaluating the Comparability of CAP Device for the Delivery of FMT in Critically Ill Patients - Yahoo Finance
Tend Announces Initiation of Clinical Study Evaluating the Comparability of CAP Device for the Delivery of FMT in Critically Ill Patients - Yahoo Finance
Tend ("the company"), a microbiome solutions company, today announced the initiation of clinical studies for its Gut Microbiome Collect and Prep (CAP) device to prepare capsules for Fecal Microbiota Transplant (FMT) for patients with recurrent Clostridium difficile (C. diff) infections. The results of the Massachusetts General Hospital (MGH) study may support the use of the device for improved processing of transplant material for FMT.
·finance.yahoo.com·
Tend Announces Initiation of Clinical Study Evaluating the Comparability of CAP Device for the Delivery of FMT in Critically Ill Patients - Yahoo Finance